A pilot double-blind placebo-controlled trial of pioglitazone as adjunctive treatment to risperidone: Effects on aberrant behavior in children with autism

Authors:

Abstract
No abstract available
Funding Information
  • Tehran University of Medical Sciences to Prof. Shahin Akhondzadeh (16043)

This publication has 29 references indexed in Scilit: